nach oben

Quality of Life Research

Erschienen in:

01.08.2007 | Original Paper

Health related quality of life in different states of breast cancer

verfasst von: Mathias Lidgren, Nils Wilking, Bengt Jönsson, Clas Rehnberg

Erschienen in: Quality of Life Research | Ausgabe 6/2007

Einloggen, um Zugang zu erhalten

Abstract

Objectives

The aim of this study was to describe the health related quality of life (HRQoL) in different breast cancer disease states using preference-based measures.

Material and Methods

A total of 361 consecutive breast cancer patients attending the breast cancer outpatient clinic at Karolinska University hospital Solna for outpatient visits between April and May 2005 were included in the study. The EQ-5D self classifier and a direct Time Trade Off (TTO) question were used to estimate the HRQoL in different breast cancer disease states.

Results

Patients in their first year after a primary breast cancer had a mean EQ-5D index value of 0.696 (95% confidence interval (CI): 0.634–0.747)). Patients in their first year after a recurrence had a mean EQ-5D index value of 0.779 (CI: 0.700–0.849). Patients who had not had a primary breast cancer diagnosis or a recurrence during the previous year had a mean EQ-5D index value of 0.779 (CI: 0.745–0.811). Patients with metastatic disease reported the lowest HRQoL values, and had a mean EQ-5D index value of 0.685 (CI: 0.620–0.735). The main driver behind the reduction in HRQoL was pain and discomfort as well as anxiety and depression. TTO values were higher for all diseases states compared to the EQ-5D index values.

Conclusion

This study shows that breast cancer is associated with a reduction in HRQoL. This effect is most pronounced for patients with metastatic disease.

First year after primary breast cancer.

First year after recurrence.

Second and following years after primary breast cancer or recurrence.

Metastatic disease.

The National Board of Health, Welfare. (2005). Cancer Incidence in Sweden 2004. Stockholm: Official Statistics of Sweden.

The National Board of Health and Welfare. (2005). Causes of death 2003. Stockholm: Official Statistics of Sweden.

Slamon, D. J., Leyland-Jones, B., Shak, S., et al. (2001). Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. The New England Journal of Medicine, 344(11), 783–792.PubMedCrossRef

Bishop, J. F., Dewar, J., Toner, G. C., et al. (1999). Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer. Journal of Clinical Oncology, 17(8), 2355–2364.PubMed

Chan, S., Friedrichs, K., Noel, D., et al. (1999). Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer. Journal of Clinical Oncology, 17(8), 2341–2354.PubMed

Drummond, M., Sculpher, M., Torrance, G., O’Brien, B., & Stoddart G. (2005). Methods for the Economic Evaluation of Health Care Programmes. 3rd ed. Oxford: Oxford Medical Publications.

Torrance, G. (1976). Social preferences for health states: An empirical evaluation of three measurments techniques. Socio-Economic Planning Sciences, 10, 129–136.CrossRef

EuroQol Group. (1990). EuroQol—A new facility for the measurment of health-related quality of life. Health Policy, 16, 199–208.CrossRef

EuroQol Group hompage. http://www.euroqol.org. Accessed November 2nd, 2006.

10.

Dolan, P. (1997). Modeling valuations for EuroQol health states. Medical Care, 35(11), 1095–1108.PubMedCrossRef

11.

Gold, M., Siegel, J., Russel, L., & Wienstein, M. (1996). Cost-effectiveness in health and medicine. New York: Oxford University Press.

12.

Johannesson, M. (1996). Theory and Methods of Economic Evaluation of Health. Care: Kluwer Academic Publisher.

13.

Conner-Spady, B. L., Cumming, C., Nabholtz, J. M., Jacobs, P., & Stewart, D. (2005). A longitudinal prospective study of health-related quality of life in breast cancer patients following high-dose chemotherapy with autologous blood stem cell transplantation. Bone Marrow Transplant, 36(3), 251–259.PubMedCrossRef

14.

Perez, D. J., Williams, S. M., Christensen, E. A., McGee, R. O., & Campbell, A. V. (2001). A longitudinal study of health related quality of life and utility measures in patients with advanced breast cancer. Quality of Life Research, 10(7), 587–593.PubMedCrossRef

15.

Jansen, S. J., Kievit, J., Nooij, M. A., & Stiggelbout, A. M. (2001). Stability of patients’ preferences for chemotherapy: The impact of experience. Medical Decision Making, 21(4), 295–306.PubMedCrossRef

16.

Hall, J., Gerard, K., Salkeld, G., & Richardson, J. (1992). A cost utility analysis of mammography screening in Australia. Social Science & Medicine, 34(9), 993–1004.CrossRef

17.

Earle, C. C., Chapman, R. H., Baker, C. S., et al. (2000). Systematic overview of cost-utility assessments in oncology. Journal of Clinical Oncology, 18(18), 3302–3317.PubMed

18.

Briggs, A. H., Wonderling, D. E., & Mooney, C. Z. (1997). Pulling cost-effectiveness analysis up by its bootstraps: A non-parametric approach to confidence interval estimation. Health Economics, 6(4), 327–340.PubMedCrossRef

19.

Burstrom, K., Johannesson, M., & Diderichsen, F. (2006). A comparison of individual and social time trade-off values for health states in the general population. Health Policy, 76(3), 359–370.PubMedCrossRef

20.

Zethraeus, N., & Johannesson, M. (1999). A comparison of patient and social tariff values derived from the time trade-off method. Health Economics, 8(6), 541–545.PubMedCrossRef

21.

Svenska bröstcancergruppen. (2003). Nationellt vårdprogram för bröstcancer. Stockholm.

22.

Wilson, R. W., Hutson, L. M., & Vanstry, D. (2005). Comparison of 2 quality-of-life questionnaires in women treated for breast cancer: The RAND 36–Item Health Survey and the Functional Living Index-Cancer. Physical Therapy, 85(9), 851–860.PubMed

23.

Whelan, T. J., Goss, P. E., Ingle, J. N., et al. (2005). Assessment of quality of life in MA.17: A randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women. Journal of Clinical Oncology, 23(28), 6931–6940.PubMedCrossRef

24.

Wardley, A., Davidson, N., Barrett-Lee, P., et al. (2005). Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases: A randomised, crossover study of community vs hospital bisphosphonate administration. British Journal of Cancer, 92(10), 1869–1876.PubMedCrossRef

25.

Schou, I., Ekeberg, O., Sandvik, L., Hjermstad, M.J., & Ruland, C. M. (2005). Multiple predictors of health-related quality of life in early stage breast cancer. Data from a year follow-up study compared with the general population. Quality of Life Research, 14(8), 1813–1823.PubMedCrossRef

26.

Peppercorn, J., Herndon, J., 2nd, Kornblith, A. B., et al. (2005). Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy: Results from Cancer and Leukemia Group B 9066. Cancer, 104(8), 1580–1589. Oct 15.

27.

Kendall, A. R., Mahue-Giangreco, M., Carpenter, C. L., Ganz, P. A., & Bernstein, L. (2005). Influence of exercise activity on quality of life in long-term breast cancer survivors. Quality of Life Research, 14(2), 361–371.PubMedCrossRef

28.

Gordon, L. G., Battistutta, D., Scuffham, P., Tweeddale, M., & Newman, B. (2005). The impact of rehabilitation support services on health-related quality of life for women with breast cancer. Breast Cancer Research and Treatment, 93(3), 217–226.PubMedCrossRef

29.

Fehlauer, F., Tribius, S., Mehnert, A., & Rades, D. (2005). Health-related quality of life in long term breast cancer survivors treated with breast conserving therapy: Impact of age at therapy. Breast Cancer Research and Treatment, 92(3), 217–222.PubMedCrossRef

30.

Elder, E. E., Brandberg, Y., Bjorklund, T., et al. (2005). Quality of life and patient satisfaction in breast cancer patients after immediate breast reconstruction: A prospective study. Breast, 14(3), 201–208.PubMedCrossRef

31.

Burckhardt, C. S., & Jones, K. D. (2005). Effects of chronic widespread pain on the health status and quality of life of women after breast cancer surgery. Health and Quality of Life Outcomes, 3(1), 30.PubMedCrossRef

32.

Avis, N. E., Crawford, S., & Manuel, J. (2005). Quality of life among younger women with breast cancer. Journal of Clinical Oncology, 23(15), 3322–3330.PubMedCrossRef

33.

Veiga, D. F., Sabino Neto, M., Ferreira L. M., et al. (2004). Quality of life outcomes after pedicled TRAM flap delayed breast reconstruction. British Journal of Plastic Surgery, 57(3), 252–257.PubMedCrossRef

34.

Schreier, A. M., & Williams, S. A. (2004). Anxiety and quality of life of women who receive radiation or chemotherapy for breast cancer. Oncology Nursing Forum, 31(1), 127–130.PubMedCrossRef

Titel: Health related quality of life in different states of breast cancer
verfasst von: Mathias Lidgren
Nils Wilking
Bengt Jönsson
Clas Rehnberg
Publikationsdatum: 01.08.2007
Verlag: Springer Netherlands
Erschienen in: Quality of Life Research / Ausgabe 6/2007
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-007-9202-8

Springer Medizin

Abstract

Objectives

Material and Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2007

Predicting quality of life impairment in chronic schizophrenia from cognitive variables

Reliability, validity, and minimally important differences of the SF-6D in systemic sclerosis

Validity, reliability and clinical relevance of EORTC QLQ-C30 and LC13 in patients with chest malignancies in a palliative setting

US and UK versions of the EQ-5D preference weights: Does choice of preference weights make a difference?

Fatigue in breast cancer survivors two to five years post diagnosis: a HEAL Study report

Measurement of overall quality of life in nursing homes through self-report: the role of cognitive impairment